PRGO FY 2023 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

FY 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$4.7B+4.6% YoY

Gross Profit

$1.7B36.1% margin

Operating Income

$152M3.3% margin

Net Income

-$13M-0.3% margin

EPS (Diluted)

$-0.09

Cash Flow

Operating Cash Flow

$406M

Free Cash Flow

$304M

Stock-Based Comp.

$69M

Balance Sheet

Total Assets

$10.8B

Total Liabilities

$6.0B

Stockholders' Equity

$4.8B

Cash & Equivalents

$751M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.7B	$4.5B	+4.6%
Gross Profit	$1.7B	$1.5B	+15.5%
Operating Income	$152M	$79M	+92.5%
Net Income	-$13M	-$141M	+91.0%